![]() |
![]() |
Teisinis statusas
Patento galiojimo terminas pasibaigęs
(51) | INT.CL. | C07D 223/14 | (2006.01) |
A61K 31/55 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 3/04 | (2006.01) | ||
A61P 9/00 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 13/02 | (2006.01) | ||
A61P 15/00 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 25/04 | (2006.01) | ||
A61P 25/06 | (2006.01) | ||
A61P 25/08 | (2006.01) | ||
A61P 25/18 | (2006.01) | ||
A61P 25/20 | (2006.01) | ||
A61P 25/22 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61P 25/32 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
C07D 223/16 | (2006.01) | ||
C07D 223/32 | (2006.01) | ||
C07D 403/04 | (2006.01) | ||
C07D 409/04 | (2006.01) | ||
C07D 487/00 | (2006.01) | ||
C07D 491/00 | (2006.01) | ||
C07D 491/04 | (2006.01) | ||
C07D 491/048 | (2006.01) | ||
C07D 513/00 | (2006.01) |
(11) | Patento numeris | 1411881 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 03718323.3 |
Europos patento paraiškos padavimo data | 2003-04-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2004-04-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2005-05-04 |
(46) | Apibrėžties vertimo paskelbimo data | 2005-08-25 |
(86) | Numeris | PCT/US2003/011076 |
Data | 2003-04-11 |
(87) | Numeris | WO 2003/086306 |
Data | 2003-10-23 |
(30) | Numeris | Data | Šalis |
372058 P | 2002-04-12 | US | |
405495 P | 2002-08-23 | US | |
434607 P | 2002-12-18 | US | |
410991 | 2003-04-10 | US |
(72) |
SMITH, Brian, US
SMITH, Jeffrey, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6166 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 5HT2C receptoriaus moduliatoriai |
5HT2C RECEPTOR MODULATORS |
Mokėjimo data | Galiojimo metai | Suma | |
2022-03-21 | 347.00 EUR |